TELS Trademark
TELS is a USPTO trademark filed by Nant Holdings IP, LLC. Status: Pending.
Prosecution Summary
Trademark Summary
The standard character mark TELS covers cells and biological preparations for medical and clinical use, namely T cells activated by tumor-associated antigens or neoantigens expressed by a tumor in class 005, along with goods/services in classes 006, 018, 044, 046, 051, and 052. It is owned by Nant Holdings IP, LLC, a Delaware limited liability company based in Culver City, California. The application is on the Principal Register under intent-to-use basis and currently awaits a Statement of Use after a second extension of time was granted on November 19, 2025.
Recent Activity
Filed November 29, 2023, the application advanced through examination, including a response to a non-final office action in October 2024, approval for publication on October 1
Trademark Facts
| Mark | TELS |
|---|---|
| Serial Number | 98290851 |
| Status | Pending |
| Filing Date | 2023-11-29 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Nant Holdings IP, LLC |
| Attorney of Record | Michael J. McCue |
| Prosecution Events | 27 |
| Latest Event | EXRA on 2025-11-19 |
Goods & Services
Cells and biological preparations intended for medical and clinical use, namely, T cells which have been activated by tumor-associated antigens or neoantigens expressed by a tumor